-
PDF
- Split View
-
Views
-
Cite
Cite
Cian Hehir, Gavin Dowling, Gavin Calpin, Barry O’Sullivan, James Martin-Smith, Roisin Dolan, 123 The Effect of Sarcopenia on Postoperative Complications in Autologous Breast Reconstruction – A Systematic Review and Meta-Analysis, British Journal of Surgery, Volume 112, Issue Supplement_6, March 2025, znaf042.074, https://doi.org/10.1093/bjs/znaf042.074
- Share Icon Share
Abstract
Sarcopenia refers to loss of muscle mass combined with associated loss in muscle function and has been demonstrated to predict postoperative complications across a range of surgical procedures. The effect of sarcopenia on outcomes in autologous breast reconstruction remains uncertain. This systematic review and meta-analysis aims to further evaluate this relationship in the context of breast reconstruction.
A systematic review of electronic databases was performed in conjunction with PRISMA guidelines. Studies reporting on postoperative complications in sarcopenic versus non-sarcopenic patients undergoing autologous breast reconstruction were included. Sarcopenia was identified by directly measuring psoas muscle cross-sectional area (PMA) on computed tomography (CT) scan. Meta-analysis was carried out on any complication reported in three or more journal articles.
Six studies were included in meta-analysis. Sarcopenic patients were found to be at a significantly increased risk of haematoma formation (OR= 1.84, 95%CI=1.06-3.18, p=0.03), but this was not associated with an increased risk of return to theatre due to haematoma (OR=1.11, 95%CI=0.36-3.38, p=0.86). There was no statistically significant difference in risk of total flap loss, partial flap loss, flap infection, flap seroma formation, donor site complications, risk of re-operation nor wound dehiscence between sarcopenic and non-sarcopenic cohorts.
This study reports that haematoma risk is significantly elevated in sarcopenic patients undergoing autologous breast reconstruction. Postoperative complication rates are otherwise comparable between sarcopenic and non-sarcopenic cohorts. Further prospective studies reporting on BMI, PMA and psoas muscle density are required.